36.17 USD
-0.38
1.04%
At close Feb 14, 4:00 PM EST
After hours
36.21
+0.04
0.11%
1 day
-1.04%
5 days
-0.55%
1 month
12.75%
3 months
5.18%
6 months
-12.25%
Year to date
6.54%
1 year
-13.47%
5 years
-33.85%
10 years
-39.35%
 

About: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Employees: 70,200

0
Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

93% more call options, than puts

Call options by funds: $200M | Put options by funds: $104M

33% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 67

1% more funds holding

Funds holding: 871 [Q2] → 883 (+12) [Q3]

2% more capital invested

Capital invested by funds: $12.4B [Q2] → $12.7B (+$255M) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 10 [Q2] → 10 (+0) [Q3]

0.32% less ownership

Funds ownership: 7.8% [Q2] → 7.48% (-0.32%) [Q3]

4% less repeat investments, than reductions

Existing positions increased: 302 | Existing positions reduced: 316

Research analyst outlook

We haven’t received any recent analyst ratings for GSK.

Financial journalist opinion

Based on 141 articles about GSK published over the past 30 days

Neutral
Accesswire
5 hours ago
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129950&wire=1 or contact Joseph E. Levi, Esq.
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
Neutral
Accesswire
7 hours ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129944&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
Neutral
GlobeNewsWire
7 hours ago
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK
NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the “Class Period”), of the important April 7, 2025 lead plaintiff deadline.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK
Neutral
Accesswire
10 hours ago
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129923&wire=1 or contact Joseph E. Levi, Esq.
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
Neutral
PRNewsWire
10 hours ago
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK , Feb. 16, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE: GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period").
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Neutral
Accesswire
14 hours ago
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129877&wire=1 or contact Joseph E. Levi, Esq.
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
Neutral
Accesswire
15 hours ago
GSK plc Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE:GSK) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.
GSK plc Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Neutral
Accesswire
18 hours ago
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK
NEW YORK, NY / ACCESS Newswire / February 16, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129808&wire=1 or contact Joseph E. Levi, Esq.
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK
Neutral
Accesswire
19 hours ago
GSK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period").
GSK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Neutral
Accesswire
1 day ago
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)
NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129785&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)
Charts implemented using Lightweight Charts™